These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 38490509)
1. Targeting CAMK2N1/CAMK2 inhibits invasion, migration and angiogenesis of non-small cell lung cancer by promoting autophagy and apoptosis via AKT/mTOR signaling pathway. Wang Q; Zhang C; Jiang H; He W Gene; 2024 Jun; 913():148375. PubMed ID: 38490509 [TBL] [Abstract][Full Text] [Related]
2. CDKL3 Promotes Non-small Cell Lung Cancer by Suppressing Autophagy Via Activation of PI3K/Akt/mTOR Pathway. Li R; Chai L; Lei L; Guo R; Wen X Mol Biotechnol; 2023 Sep; 65(9):1421-1431. PubMed ID: 36630073 [TBL] [Abstract][Full Text] [Related]
3. PM02734 (elisidepsin) induces caspase-independent cell death associated with features of autophagy, inhibition of the Akt/mTOR signaling pathway, and activation of death-associated protein kinase. Ling YH; Aracil M; Zou Y; Yuan Z; Lu B; Jimeno J; Cuervo AM; Perez-Soler R Clin Cancer Res; 2011 Aug; 17(16):5353-66. PubMed ID: 21690574 [TBL] [Abstract][Full Text] [Related]
4. Luteoloside induces G Zhou M; Shen S; Zhao X; Gong X Biochem Biophys Res Commun; 2017 Dec; 494(1-2):263-269. PubMed ID: 29024631 [TBL] [Abstract][Full Text] [Related]
5. Plin2 inhibits autophagy via activating AKT/mTOR pathway in non-small cell lung cancer. Wang Y; Hu Y; Xu R; Jin X; Jiao W Exp Cell Res; 2024 Feb; 435(2):113955. PubMed ID: 38301990 [TBL] [Abstract][Full Text] [Related]
6. Ganoderic acid DM induces autophagic apoptosis in non-small cell lung cancer cells by inhibiting the PI3K/Akt/mTOR activity. Xia J; Dai L; Wang L; Zhu J Chem Biol Interact; 2020 Jan; 316():108932. PubMed ID: 31874162 [TBL] [Abstract][Full Text] [Related]
7. SIRT6 through PI3K/Akt/mTOR signaling pathway to enhance radiosensitivity of non-Small cell lung cancer and inhibit tumor progression. Xiong L; Tan B; Lei X; Zhang B; Li W; Liu D; Xia T IUBMB Life; 2021 Sep; 73(9):1092-1102. PubMed ID: 34033225 [TBL] [Abstract][Full Text] [Related]
8. FAM83D promotes epithelial-mesenchymal transition, invasion and cisplatin resistance through regulating the AKT/mTOR pathway in non-small-cell lung cancer. Yin C; Lin X; Wang Y; Liu X; Xiao Y; Liu J; Snijders AM; Wei G; Mao JH; Zhang P Cell Oncol (Dordr); 2020 Jun; 43(3):395-407. PubMed ID: 32006253 [TBL] [Abstract][Full Text] [Related]
9. MiR-206 inhibits HGF-induced epithelial-mesenchymal transition and angiogenesis in non-small cell lung cancer via c-Met /PI3k/Akt/mTOR pathway. Chen QY; Jiao DM; Wu YQ; Chen J; Wang J; Tang XL; Mou H; Hu HZ; Song J; Yan J; Wu LJ; Chen J; Wang Z Oncotarget; 2016 Apr; 7(14):18247-61. PubMed ID: 26919096 [TBL] [Abstract][Full Text] [Related]
10. Targeting SNORA38B attenuates tumorigenesis and sensitizes immune checkpoint blockade in non-small cell lung cancer by remodeling the tumor microenvironment via regulation of GAB2/AKT/mTOR signaling pathway. Zhuo Y; Li S; Hu W; Zhang Y; Shi Y; Zhang F; Zhang J; Wang J; Liao M; Chen J; Qian H; Li D; Sun C J Immunother Cancer; 2022 May; 10(5):. PubMed ID: 35577506 [TBL] [Abstract][Full Text] [Related]
11. PTPRH promotes the progression of non-small cell lung cancer via glycolysis mediated by the PI3K/AKT/mTOR signaling pathway. Wang S; Cheng Z; Cui Y; Xu S; Luan Q; Jing S; Du B; Li X; Li Y J Transl Med; 2023 Nov; 21(1):819. PubMed ID: 37974250 [TBL] [Abstract][Full Text] [Related]
12. Quercetin suppresses the mobility of breast cancer by suppressing glycolysis through Akt-mTOR pathway mediated autophagy induction. Jia L; Huang S; Yin X; Zan Y; Guo Y; Han L Life Sci; 2018 Sep; 208():123-130. PubMed ID: 30025823 [TBL] [Abstract][Full Text] [Related]
13. FKBP4 Accelerates Malignant Progression of Non-Small-Cell Lung Cancer by Activating the Akt/mTOR Signaling Pathway. Meng W; Meng J; Jiang H; Feng X; Wei D; Ding Q Anal Cell Pathol (Amst); 2020; 2020():6021602. PubMed ID: 33354489 [TBL] [Abstract][Full Text] [Related]
14. Kaempferol promotes non-small cell lung cancer cell autophagy via restricting Met pathway. Wang R; Deng Z; Zhu Z; Wang J; Yang X; Xu M; Wang X; Tang Q; Zhou Q; Wan X; Wu W; Wang S Phytomedicine; 2023 Dec; 121():155090. PubMed ID: 37738907 [TBL] [Abstract][Full Text] [Related]
15. Jervine inhibits non-small cell lung cancer (NSCLC) progression by suppressing Hedgehog and AKT signaling via triggering autophagy-regulated apoptosis. Lei W; Huo Z Biochem Biophys Res Commun; 2020 Dec; 533(3):397-403. PubMed ID: 32972750 [TBL] [Abstract][Full Text] [Related]
16. Curcumin inhibits migration and invasion of non-small cell lung cancer cells through up-regulation of miR-206 and suppression of PI3K/AKT/mTOR signaling pathway. Wang N; Feng T; Liu X; Liu Q Acta Pharm; 2020 Sep; 70(3):399-409. PubMed ID: 32074070 [TBL] [Abstract][Full Text] [Related]
17. Silencing the FOLR2 Gene Inhibits Cell Proliferation and Increases Apoptosis in the NCI-H1650 Non-Small Cell Lung Cancer Cell Line via Inhibition of AKT/Mammalian Target of Rapamycin (mTOR)/Ribosomal Protein S6 Kinase 1 (S6K1) Signaling. Xu X; Jiang J; Yao L; Ji B Med Sci Monit; 2018 Nov; 24():8064-8073. PubMed ID: 30415267 [TBL] [Abstract][Full Text] [Related]
18. Co-treatment with BEZ235 enhances chemosensitivity of A549/DDP cells to cisplatin via inhibition of PI3K/Akt/mTOR signaling and downregulation of ERCC1 expression. Xia A; Li H; Li R; Lu L; Wu X Oncol Rep; 2018 Oct; 40(4):2353-2362. PubMed ID: 30066933 [TBL] [Abstract][Full Text] [Related]
19. Isoflurane Promotes Non-Small Cell Lung Cancer Malignancy by Activating the Akt-Mammalian Target of Rapamycin (mTOR) Signaling Pathway. Zhang W; Shao X Med Sci Monit; 2016 Nov; 22():4644-4650. PubMed ID: 27897153 [TBL] [Abstract][Full Text] [Related]
20. Effect of microRNA-135a on Cell Proliferation, Migration, Invasion, Apoptosis and Tumor Angiogenesis Through the IGF-1/PI3K/Akt Signaling Pathway in Non-Small Cell Lung Cancer. Zhou Y; Li S; Li J; Wang D; Li Q Cell Physiol Biochem; 2017; 42(4):1431-1446. PubMed ID: 28715819 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]